about
Prostacyclins in pulmonary arterial hypertension: the need for earlier therapy.Healthcare resource utilization and costs for patients with pulmonary arterial hypertension: real-world documentation of functional class.Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption.Stability-Indicating Gradient RP-LC Method for the Determination of Process and Degradation Impurities in Bosentan Monohydrate: An Endothelin Receptor Antagonist
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of severe pulmonary arterial hypertension.
@en
Management of severe pulmonary arterial hypertension.
@nl
type
label
Management of severe pulmonary arterial hypertension.
@en
Management of severe pulmonary arterial hypertension.
@nl
prefLabel
Management of severe pulmonary arterial hypertension.
@en
Management of severe pulmonary arterial hypertension.
@nl
P1476
Management of severe pulmonary arterial hypertension.
@en
P2093
G Simonneau
J-L Vachiéry
P304
P356
10.1183/09059180.00008010
P577
2010-12-01T00:00:00Z